Drreddys Laboratories traded at $50.92 this Tuesday May 17th, increasing $0.24 or 0.46 percent since the previous trading session. Looking back, over the last four weeks, Drreddys Laboratories gained 7.96 percent. Over the last 12 months, its price fell by 29.28 percent. Looking ahead, we forecast Drreddys Laboratories to be priced at 49.27 by the end of this quarter and at 45.42 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Aurora Cannabis Inc 3.84 0.05 1.32% -56.90%
ANI Pharmaceuticals 29.60 0.83 2.87% -19.54%
Bayer 64.36 0.24 0.37% 15.61%
Cipla 954.70 16.70 1.78% 5.61%
Corcept Therapeutics 19.73 0.69 3.62% -7.85%
Catalent 100.70 3.03 3.10% 0.36%
Endo International 1.17 0.02 1.30% -79.53%
GlaxoSmithKline 1,788.90 2.70 0.15% 30.88%
Hikma Pharmaceutical 1,745.00 18.50 1.07% -27.38%
Horizon Pharma 92.85 2.03 2.24% 0.02%
Jazz Pharmaceuticals 150.60 3.45 2.34% -15.95%
Lannett 0.54 -0.002 -0.45% -88.75%
Lonza Group 550.60 -2.20 -0.40% -2.24%
Novartis 87.80 0.39 0.45% 10.14%
Phibro Animal Health 18.91 0.38 2.05% -32.63%
Prestige Brands 57.93 0.92 1.61% 17.21%
Pacira 62.00 -1.54 -2.42% 0.65%
Powershares High Yield Orate Bond Portfolio 17.46 0.02 0.09% -10.07%
Drreddys Laboratories 50.92 0.24 0.46% -29.28%
Richter Gedeon 7,170.00 275.00 3.99% -14.49%
Sun Pharmaceuticals 900.80 9.05 1.01% 28.06%
Supernus Pharmaceuticals 27.58 0.14 0.51% -10.86%
Teva Pharmaceutical Industries Ltd 2,771.00 -41.00 -1.46% -21.46%
United States Oil Fund 83.16 0.05 0.06% 83.21%
Canopy Growth Corp 7.43 0.08 1.09% -73.41%


Drreddys Laboratories
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.